...
首页> 外文期刊>BMC Ophthalmology >Artisan versus Artiflex phakic intraocular lens implantation in the treatment of moderate to high myopia: meta-analysis
【24h】

Artisan versus Artiflex phakic intraocular lens implantation in the treatment of moderate to high myopia: meta-analysis

机译:工匠与Artiflex Phakic眼透镜植入治疗中度至高近视:Meta分析

获取原文
           

摘要

To compare the postoperative safety, efficacy, predictability, visual quality and biomechanics after implantation of Artisan vs. Artiflex phakic intraocular lenses (PIOLs). Pubmed, Embase, Cochrane Library were conducted up from January 2000 to February 2020. Comparative clinical studies reporting in accordance with the eligibility criteria were included in this meta-analysis. The pooled weighted mean differences (WMDs) and odds ratios (ORs) with corresponding 95% confidence intervals were calculated. Comparative trials with myopia patients were selected in this review. The pooled WMD and OR estimates statistical significance in terms of postoperative best corrected visual acuity (BCVA), efficacy, postoperative spherical equivalence (SE), predictability, contrast sensitivity and mean intraocular higher-order aberrations (HOA) (mm) for a 6-mm pupil, manifesting that Artiflex PIOL showed evident beneficial effect for correcting myopia compared to Artisan PIOL. There was no significant difference in the incidence of complications between the two groups. Both of two techniques were safe and effective for myopia and compared to Artisan PIOL, Artiflex PIOL had significant improvement in efficacy, predictability, contrast sensitivityand HOA, except safety and complications in the treatment of moderate to high myopia.
机译:在植入工匠与Artiflex Phakic眼内晶状体(Piols)后比较术后安全性,疗效,可预测性,视觉质量和生物力学。 PubMed,Embase,Cochrane图书馆于2000年1月至2020年2月进行。根据资格标准的比较临床研究包括在该荟萃分析中。计算汇集的加权平均差(WMDS)和具有相应95%置信区间的差异的差异比率(或者)。在本综述中选择了与近视患者的比较试验。汇总的WMD和或估计术后最佳矫正视力(BCVA),疗效,术后球形等当量(SE),可预测性,对比度敏感性和平均高阶畸变(HOA)(MM)的统计学意义.6- MM瞳孔,表现出Artiflex PIOL与Artisan Piol相比校正近视的明显有益效果。两组之间并发症发生率没有显着差异。两种技术对近视是安全有效的,与Artiflex PIOL相比,Artiflex Piol对疗效,可预测性,对比度敏感性和HOA的显着改善,除了安全和并发症,治疗中度至高近视。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号